Difference between revisions of "2.16.840.1.113883.10.22.3.2"
(Automatic ADBot page (6c3cbd76b11b19d7541323c437b9e573f3d3e35d)) |
(Automatic ADBot page (6c3cbd76b11b19d7541323c437b9e573f3d3e35d)) |
||
Line 5: | Line 5: | ||
=Template ''IPSSectionAllergiesOrIntolerances''= | =Template ''IPSSectionAllergiesOrIntolerances''= | ||
− | <p>This section documents the relevant allergies or intolerances (conditions) for that patient, describing the kind of reaction (e.g. rash, anaphylaxis,..); preferably the agents that cause it; and optionally the criticality and the certainty of the allergy. | + | <p> |
+ | This section documents the relevant allergies or intolerances (conditions) for that patient, describing the kind of reaction (e.g. rash, anaphylaxis,..); preferably the agents that cause it; and optionally the criticality and the certainty of the allergy. | ||
+ | At a minimum, it should list currently active and any relevant historical allergies and adverse reactions. | ||
+ | If no information about allergies is available, or if no allergies are known this should be clearly documented in the section.The optional author and informant elements are used when necessary to convey the provenance and authoring of the section content in case it is different from what is announced in the CDA | ||
+ | header. | ||
+ | </p> | ||
==Actual version== | ==Actual version== | ||
{{:{{BASEPAGENAME}}/dynamic}} | {{:{{BASEPAGENAME}}/dynamic}} | ||
Line 11: | Line 16: | ||
==List of all versions of this template== | ==List of all versions of this template== | ||
*[[2.16.840.1.113883.10.22.3.2/static-2016-11-11T000000|2016-11-11 (Under pre-publication review)]] | *[[2.16.840.1.113883.10.22.3.2/static-2016-11-11T000000|2016-11-11 (Under pre-publication review)]] | ||
− | <!-- | + | <!--b3c7d503a0a8d27bf3c3e2c7b10580c10ed65fa7--> |
Revision as of 14:41, 5 January 2021
Comments on this page |
---|
Template IPSSectionAllergiesOrIntolerances
This section documents the relevant allergies or intolerances (conditions) for that patient, describing the kind of reaction (e.g. rash, anaphylaxis,..); preferably the agents that cause it; and optionally the criticality and the certainty of the allergy. At a minimum, it should list currently active and any relevant historical allergies and adverse reactions. If no information about allergies is available, or if no allergies are known this should be clearly documented in the section.The optional author and informant elements are used when necessary to convey the provenance and authoring of the section content in case it is different from what is announced in the CDA header.
Actual version